REGENXBIO

$35.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-0.75%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell REGENXBIO and other stocks, options, and ETFs commission-free!

About RGNX

REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD. The listed name for RGNX is REGENXBIO Inc. Common Stock.

CEO
Kenneth T. Mills
Employees
257
Headquarters
Rockville, Maryland
Founded
2008
Market Cap
1.33B
Price-Earnings Ratio
Dividend Yield
Average Volume
322.71K
High Today
$35.99
Low Today
$35.20
Open Price
$35.97
Volume
166.51K
52 Week High
$54.97
52 Week Low
$20.03

Collections

RGNX Earnings

-$1.08
-$0.64
-$0.21
$0.23
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, After Hours

You May Also Like